Cargando…

Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis

As a first-line immunosuppressant to maintain remission in Crohn's disease, 6-mercaptopurine (6-MP) has been commonly used. A rare, unpredictable, dose-independent and idiosyncratic reaction to this medication is acute pancreatitis. Unlike other side effects of this drug which have been well ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Ethan K, Stratulat, Eugeniu, Judge, Gurjeet, Shafique, Seaf, Ladel, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060005/
https://www.ncbi.nlm.nih.gov/pubmed/37007369
http://dx.doi.org/10.7759/cureus.35554
_version_ 1785017012000391168
author Chambers, Ethan K
Stratulat, Eugeniu
Judge, Gurjeet
Shafique, Seaf
Ladel, Luisa
author_facet Chambers, Ethan K
Stratulat, Eugeniu
Judge, Gurjeet
Shafique, Seaf
Ladel, Luisa
author_sort Chambers, Ethan K
collection PubMed
description As a first-line immunosuppressant to maintain remission in Crohn's disease, 6-mercaptopurine (6-MP) has been commonly used. A rare, unpredictable, dose-independent and idiosyncratic reaction to this medication is acute pancreatitis. Unlike other side effects of this drug which have been well characterized and are often dose-dependent, acute pancreatitis is an uncommon adverse effect not frequently encountered in clinical practice. In this case report, we describe a 40-year-old man with Crohn's disease who developed acute pancreatitis within two weeks of starting 6-MP. Discontinuation of the drug followed by fluid resuscitation led to the overall improvement of symptoms within 72 hours. No complications were noted during the follow-up. It is our intention to raise awareness for this lesser-known side effect with this case report and to urge physicians to provide thorough counseling prior to starting on this medication, especially in patients with inflammatory bowel disease (IBD). Additionally, we hope to reinforce this disease entity as a differential for acute pancreatitis and aim to emphasize the importance of detailed medication reconciliations with this report, especially in the emergency department, to enable quick diagnoses and limit unnecessary treatments.
format Online
Article
Text
id pubmed-10060005
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100600052023-03-30 Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis Chambers, Ethan K Stratulat, Eugeniu Judge, Gurjeet Shafique, Seaf Ladel, Luisa Cureus Internal Medicine As a first-line immunosuppressant to maintain remission in Crohn's disease, 6-mercaptopurine (6-MP) has been commonly used. A rare, unpredictable, dose-independent and idiosyncratic reaction to this medication is acute pancreatitis. Unlike other side effects of this drug which have been well characterized and are often dose-dependent, acute pancreatitis is an uncommon adverse effect not frequently encountered in clinical practice. In this case report, we describe a 40-year-old man with Crohn's disease who developed acute pancreatitis within two weeks of starting 6-MP. Discontinuation of the drug followed by fluid resuscitation led to the overall improvement of symptoms within 72 hours. No complications were noted during the follow-up. It is our intention to raise awareness for this lesser-known side effect with this case report and to urge physicians to provide thorough counseling prior to starting on this medication, especially in patients with inflammatory bowel disease (IBD). Additionally, we hope to reinforce this disease entity as a differential for acute pancreatitis and aim to emphasize the importance of detailed medication reconciliations with this report, especially in the emergency department, to enable quick diagnoses and limit unnecessary treatments. Cureus 2023-02-27 /pmc/articles/PMC10060005/ /pubmed/37007369 http://dx.doi.org/10.7759/cureus.35554 Text en Copyright © 2023, Chambers et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Chambers, Ethan K
Stratulat, Eugeniu
Judge, Gurjeet
Shafique, Seaf
Ladel, Luisa
Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title_full Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title_fullStr Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title_full_unstemmed Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title_short Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis
title_sort stomach pain upon stomach pain: medication-induced pancreatitis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060005/
https://www.ncbi.nlm.nih.gov/pubmed/37007369
http://dx.doi.org/10.7759/cureus.35554
work_keys_str_mv AT chambersethank stomachpainuponstomachpainmedicationinducedpancreatitis
AT stratulateugeniu stomachpainuponstomachpainmedicationinducedpancreatitis
AT judgegurjeet stomachpainuponstomachpainmedicationinducedpancreatitis
AT shafiqueseaf stomachpainuponstomachpainmedicationinducedpancreatitis
AT ladelluisa stomachpainuponstomachpainmedicationinducedpancreatitis